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INTRODUCTION
Autoimmune hemolytic anemia (AIHA) are group of clinical conditions characterized by production of autoantibodies directed against RBC membrane antigen leading to its premature destruction. 1 These are uncommon causes of anemia in children 1, 2 and should be considered in a differential diagnosis of acquired hemolytic anemia or secondary manifestations of autoimmune diseases, lymphoproliferative disease and viral or mycoplasma infections. 1 Here, we report a case of a 14 year-old girl with Coomb's negative autoimmune hemolytic anemia which responded with prednisolone and had lab evidence of Vitamin B12 deÞ ciency.
CASE REPORT
A 14 year-old girl was presented to emergency with fever for 14 days, vomiting for 3 days, paleness of body for three days and passing of dark colored urine for one day. She was under oral oß oxacin for last Þ ve days from a private clinic. There was no history of seizure, blood transfusion, skin rashes, joint pain, bleeding from any site and family history of bleeding problems. On examination child was pale, icteric, pyrexic and was in shock with normal systemic examination except for palpable spleen. There was no evidence of KayserFleischer ring on ophthalmological examination. She was successfully resuscitated. Her investigationsare shown in Table 1 . The child was diagnosed with acute hemolytic anemia secondary to infection and was treated with intravenous antibiotics, blood transfusions and empiric antimalarial treatment however we could not perform IgM serology, seroconversion identiÞ cation for mycoplasma, Epstein-Barr virus, cytomegalovirus and parvovirus to prove such infection. The child was discharged after eight days of hospital admission and had hemoglobin, WBC with absolute neutrophils count and platelet count normal at regular follow up.
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Ten months after remaining asymptomatic with normal hemoglobin level, she presented again with complaints of dizziness, headache, vomiting, and decreased urine output for one day. On examination child was pale, icteric with normal vitals and normal systemic examination except for palpable spleen and livedo reticularis in lower limbs. Her investigations were shown in Table 1 . In addition, reactive lymphocytes with clumping of RBCs in room temperature were seen in peripheral smear indicating the possibility of cold agglutination. During hospital stay, she developed high grade fever with serial decrease in hemoglobin level. The child was transfused with packed RBC along with intravenous antibiotics and was also treated with Vitamin B 12 with no further improvement in hemoglobin level. The clinical course, examination Þ nding and investigation reports were suggestive of immune mediated hemolytic anemia probably primary in origin. Thus oral prednisolone was started with which her hemoglobin level raised consistently and did not require further transfusions. The child went into remission after six weeks of daily steroid followed by slow tapering over month. At present the child is on regular follow up with normal hemoglobin level without any steroids.
DISCUSSION AND REVIEW OF LITERATURE
Immune hemolytic anemia can be classiÞ ed to autoimmune, alloimmune and drug-induced. Autoimmune hemolytic anemia is further classiÞ ed into warm AIHA, cold agglutinin syndrome, paroxysmal cold hemoglobinuria, mixed type AIHA and drug-induced AIHA based on nature of antibodies, while they are classiÞ ed as primary (idiopathic) and secondary (manifestation of another disease) based on etiology. 1 The diagnosis of AIHA is based on hemoglobin concentration less than 11 g/dL, a positive direct antiglobulin test (DAT) and at least one of the following features of hemolysis: reticulocyte count greater than 120×10 9 /L, haptoglobin less than 10 mg/dL, and total bilirubin greater than 1 mg/dL. 2 A positive DAT suggests diagnosis of AIHA however DAT negative AIHA occurs in 5-10% of patients.
3, 4 AIHA with negative DAT are uncommon and requires investigations to exclude secondary causes and regular follow up as it is difÞ cult to establish that hemolysis is due to autoimmune etiology. 3 Negative DAT may be due to presence of IgG autoantibodies in quantities lesser than detectable threshold for DAT, IgA or IgM autoantibodies and low afÞ nity autoantibodies. 4 The Natural killer cell mediated antibody independent cytotoxicity also has been postulated in the pathogenesis of AIHA which may also contribute to negative DAT. 4 The DAT in developing countries is done by conventional tube method which has low sensitivity that may cause false negative DAT and delays the diagnosis. 5 However repeat DAT done by gel technique was also negative in our patient as in some cases, repeat evaluation of DAT may show positive result. 6 There is no single optimal test for investigation of AIHA with negative DAT and there is need for combination of tests to detect different antibodies. 7 Such combination of techniques includes ß ow cytometry, enzyme linked antiglobins test, solid phase or direct polybrene. 7, 8 However these techniques are expensive and are not easily available in our country. Despite the difference in pathologic mechanisms in DAT positive and negative AIHA, there is no difference in terms of effectiveness of steroid therapy, survival at one year and long term complications between these two conditions. 9 However, patients with DAT negative AIHA clinically have milder degree of hemolysis and require low doses of steroids for maintenance as compared to patients with DAT positive AIHA. 9 Due to lack of facilities, serological tests for Epstein-Barr virus, Mycoplasma, Parvo virus and Cytomegalovirus could not be performed which was the main limitation. These serological tests are considered important to exclude AIHA secondary to these infections. 2 AIHA secondary to infections was considered less likely in this patient due to compatible clinical picture and recurrent acute hemolysis. 2 There was unusual Þ nding of Vitamin B12 deÞ ciency in our patient. Despite treatment with Vitamin B12, there was no clinical improvement and only after initiation of oral prednisolone, hemolytic activity was reduced thus obviating need for further transfusions. Vitamin B12 deÞ ciency has been reported to cause hemolytic anemia. 10 However it is unlikely to be a primary cause of hemolysis in this child and the authors could not Þ nd the literature regarding association of Vitamin B12 deÞ ciency with autoimmune hemolytic anemia.
In conclusion, high degree of clinical suspicion of autoimmune hemolytic anemia should be made in patients presenting with acute hemolysis and should be diagnosed after exclusion of secondary causes by appropriate investigations including DAT. Negative DAT does not rule out possibility of AIHA and in such cases compatible clinical course help in diagnosis of AIHA as demonstrated in this patient.
